Body System Event | Epoprostenol, N = 97 |
---|---|
No. of subjects with ≥ 1 adverse events (%) | 44 (45) |
Cardiovascular system (%) | |
Any event | 27* (28) |
Right-heart failure | 21 (22) |
Hypotension | 3 (3) |
Bradycardia | 1 (1) |
Heart arrest | 1 (1) |
Shock | 1 (1) |
Vasculitis | 1 (1) |
Respiratory system (%) | |
Any event | 7 (7) |
Lung disorder | 3 (3) |
Respiratory disorder | 3 (3) |
Dyspnea | 1 (1) |
Body as a whole (%) | |
Any event | 6 (6) |
Reaction unevaluable | 2 (2) |
Sepsis | 2 (2) |
Sudden death | 2 (2) |
Urinogenital system (%) | |
Any event | 2 (2) |
Kidney failure | 2 (2) |
Digestive system (%) | |
Any event | 1 (1) |
Hemorrhage gastrointestinal | 1 (1) |
Metabolic and nutritional disorder (%) | |
Any event | 1 (1) |
Hyperkalemia | 1 (1) |
↵* One subject had more than one adverse event.